Journal of Clinical Virology
Volume 46 , Pages S6-S10 , December 2009

Congenital cytomegalovirus (CMV) epidemiology and awareness

Received 11 June 2009 ,Accepted 4 September 2009.

References 

  1. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health. 2005;5(1):70
  2. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253–276
  3. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;
  4. Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008;41(2):57–62
  5. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104(1 Pt 1):55–60
  6. Istas AS, Demmler GJ, Dobbins JG, Stewart JA. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis. 1995;20(3):665–670
  7. Noyola DE, Demmler GJ, Williamson WD, Griesser C, Sellers S, Llorente A, et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J. 2000;19(6):505–510
  8. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326(10):663–667
  9. Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006;43:1143–1151
  10. Colugnati FA, Staras SA, Dollard SC, Cannon MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis. 2007;7:71
  11. Read JS, Cannon MJ, Stanberry LR, Schuval S. Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care. 2008;38(9):274–297
  12. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001;344(18):1366–1371
  13. Fowler KB, Stagno S, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980–1990. J Infect Dis. 1993;168(3):552–556
  14. Stagno S, Dworsky ME, Torres J, Mesa T, Hirsh T. Prevalence and importance of congenital cytomegalovirus infection in three different populations. J Pediatr. 1982;101(6):897–900
  15. Hamprecht K, Maschmann J, Jahn G, Poets CF, Goelz R. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol. 2008;41(3):198–205
  16. Taber LH, Frank AL, Yow MD, Bagley A. Acquisition of cytomegaloviral infections in families with young children: a serological study. J Infect Dis. 1985;151(5):948–952
  17. Adler SP. The molecular epidemiology of cytomegalovirus transmission among children attending a day care center. J Infect Dis. 1985;152(4):760–768
  18. Ford-Jones L, Kitai IM, Davis L, et al. Cytomegalovirus infections in Toronto child-care centers: a prospective study of viral excretion in children and seroconversion among day-care providers. Pediatr Infect Dis J. 1996;15(6):507–514
  19. Murph JR, Bale JF, Murray JC, Stinski MF, Perlman S. Cytomegalovirus transmission in a Midwest day care center: possible relationship to child care practices. J Pediatrics. 1986;109:35–39
  20. Pass RF, Hutto SC, Reynolds DW, Polhill RB. Increased frequency of cytomegalovirus infection in children in group day care. Pediatrics. 1984;74(1):121–126
  21. Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE, Cannon MJ. Cytomegalovirus seroprevalence and childhood sources of infection: a population-based study among pre-adolescents in the United States. J Clin Virol. 2008;43(3):266–271
  22. Revello MG, Campanini G, Piralla A, Furione M, Percivalle E, Zavattoni M, et al. Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their families. J Med Virol. 2008;80(8):1415–1425
  23. Handsfield HH, Chandler SH, Caine VA, Meyers JD, Corey L, Medeiros E, et al. Cytomegalovirus infection in sex partners: evidence for sexual transmission. J Infect Dis. 1985;151(2):344–348
  24. Collier AC, Handsfield HH, Ashley R, Roberts PL, DeRouen T, Meyers JD, et al. Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis. 1995;171(1):33–38
  25. Stover CT, Smith DK, Schmid DS, Pellett PE, Stewart JA, Klein RS, et al. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis. 2003;187(9):1388–1396
  26. Clarke LM, Duerr A, Feldman J, Sierra MF, Daidone BJ, Landesman SH. Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community. J Infect Dis. 1996;173(1):77–82
  27. Collier AC, Handsfield HH, Roberts PL, DeRouen T, Meyers JD, Leach L, et al. Cytomegalovirus infection in women attending a sexually transmitted disease clinic. J Infect Dis. 1990;162(1):46–51
  28. Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE, Cannon MJ. Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988–1994. Sex Transm Dis. 2008;35(5):472–479
  29. Jeon J, Victor M, Adler SP, Arwady A, Demmler G, Fowler K, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol. 2006;2006:1–7
  30. Ross DS, Victor M, Sumartojo E, Cannon MJ. Women's knowledge of congenital cytomegalovirus: results from the 2005 HealthStyles survey. J Womens Health (Larchmt.). 2008;17(5):849–858
  31. American College of O, Gynecologists . Perinatal viral and parasitic infections. ACOG Practice Bulletin. vol. 20. Washington, DC: ACOG; 2000;
  32. Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy—United States, 2007. Morb Mortal Wkly Rep. 2008;57(3):65–68
  33. Zhong J, Khanna R. Vaccine strategies against human cytomegalovirus infection. Expert Rev Anti Infect Ther. 2007;5(3):449–459
  34. Pass RF, Zhang CP, Evans A, Simpson T, Andrews W, Huang ML, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med. 2009;360(12):1191–1199
  35. Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG. 2007;114(9):1113–1121
  36. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353(13):1350–1362
  37. Picone O, Vauloup-Fellous C, Cordier AG, Du Chatelet IP, Senat MV, Frydman R, et al. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG. 2009;116(May (6)):818–823
  38. Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999–2001. Birth Defects Res A: Clin Mol Teratol. 2006;76(11):747–756
  39. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health. 2001;25(3):159–167
  40. Centers for Disease C, Prevention . Spina bifida and anencephaly before and after folic acid mandate—United States, 1995–1996 and 1999–2000. Morb Mortal Wkly Rep. 2004;53(17):362–365
  41. Centers for Disease C, Prevention . HIV/AIDS Surveillance Report. vol. 13 (No. 2). 2001;
  42. Centers for Disease C, Prevention . Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children—United States, 1998–2000. Morb Mortal Wkly Rep. 2002;51(11):234–237
  43. Groseclose SL, Brathwaite WS, Hall PA, Connor FJ, Sharp P, Anderson WJ, et al. Summary of notifiable diseases—United States, 2002. Morb Mortal Wkly Rep. 2004;51(53):1–84
  44. Bate SL, Cannon MJ. A social marketing approach to building a behavioral intervention for congenital cytomegalovirus. Health Promot Pract (Online First) 2009.
  45. Kimberlin Oliver SE, Cloud GA, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46(S4):S22–S26
  46. Vauloup-Fellous C, Picone O, Cordier A-G, du Chatelet IP, Senat M-V, Frydman R, et al. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? A 3-year experience in a French hospital. J Clin Virol. 2009;46(S4):S49–S53
  47. Grosse SD, Dollard SC, Ross DS, Cannon MJ. Newborn screening for congenital cytomegalovirus: Options for hospital-based and public health programs. J Clin Virol. 2009;46(S4):S32–S36

☆ Disclaimer: The findings and conclusions in this report are those of the author and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

PII: S1386-6532(09)00418-1

doi: 10.1016/j.jcv.2009.09.002

Journal of Clinical Virology
Volume 46 , Pages S6-S10 , December 2009

Article Tools

* Image Usage & Resolution